Select Medical Holdings Co. (NYSE:SEM) Plans Quarterly Dividend of $0.06

Select Medical Holdings Co. (NYSE:SEM) declared a quarterly dividend on Thursday, February 13th, Wall Street Journal reports. Stockholders of record on Monday, March 3rd will be paid a dividend of 0.0625 per share by the health services provider on Thursday, March 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Monday, March 3rd.

Select Medical has raised its dividend by an average of 10.1% per year over the last three years. Select Medical has a payout ratio of 17.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Select Medical to earn $1.41 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 17.7%.

Select Medical Price Performance

Shares of Select Medical stock opened at $18.19 on Friday. The stock’s 50-day simple moving average is $19.06 and its 200-day simple moving average is $27.48. Select Medical has a 52 week low of $16.20 and a 52 week high of $40.98. The company has a market capitalization of $2.35 billion, a price-to-earnings ratio of 11.02, a PEG ratio of 0.64 and a beta of 1.45. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, analysts expect that Select Medical will post 1.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Monday, February 24th. Finally, Royal Bank of Canada reduced their price objective on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, February 24th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $27.25.

Insider Activity

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 17.50% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.